The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-N-((R)-1-(hydroxyamino)-1-oxo-3-phenylpropan-2-yl)-4-phenylbutanamide ID: ALA4780646
PubChem CID: 162663898
Max Phase: Preclinical
Molecular Formula: C32H35N5O5
Molecular Weight: 569.66
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(=O)NO
Standard InChI: InChI=1S/C32H35N5O5/c1-21(38)34-29(19-24-20-33-26-15-9-8-14-25(24)26)31(40)35-27(17-16-22-10-4-2-5-11-22)30(39)36-28(32(41)37-42)18-23-12-6-3-7-13-23/h2-15,20,27-29,33,42H,16-19H2,1H3,(H,34,38)(H,35,40)(H,36,39)(H,37,41)/t27-,28-,29+/m1/s1
Standard InChI Key: PGIMJXVXZNOYGC-NLDZOOGBSA-N
Molfile:
RDKit 2D
42 45 0 0 0 0 0 0 0 0999 V2000
14.8415 -5.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5492 -4.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1338 -4.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8415 -6.2239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2569 -5.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9646 -4.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6723 -5.4067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9646 -4.1809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3801 -4.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0878 -5.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3801 -4.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0878 -3.7723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0878 -2.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7974 -2.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7978 -1.7313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0895 -1.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3795 -1.7349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3826 -2.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0878 -6.2239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7955 -4.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5032 -5.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2109 -4.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5032 -6.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2109 -6.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9186 -5.4067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6263 -4.9981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2109 -4.1809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2071 -7.4507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9140 -7.8592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6226 -7.4506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6200 -6.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9126 -6.2243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2569 -6.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9646 -6.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2623 -6.9049 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7154 -6.2977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8537 -7.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0581 -7.4403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5130 -8.0424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7623 -8.8171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5618 -8.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1034 -8.3828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
2 5 1 0
5 6 1 0
6 7 1 0
6 8 2 0
7 9 1 0
9 10 1 0
9 11 1 6
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
10 19 2 0
10 20 1 0
20 21 1 0
21 22 1 0
21 23 1 1
23 24 1 0
22 25 1 0
25 26 1 0
22 27 2 0
24 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 24 1 0
5 33 1 6
33 34 1 0
34 38 1 0
37 35 1 0
35 36 1 0
36 34 2 0
37 38 2 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 569.66Molecular Weight (Monoisotopic): 569.2638AlogP: 2.57#Rotatable Bonds: 13Polar Surface Area: 152.42Molecular Species: NEUTRALHBA: 5HBD: 6#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.72CX Basic pKa: ┄CX LogP: 2.87CX LogD: 2.85Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.11Np Likeness Score: 0.02
References 1. Baggio C,Velazquez JV,Fragai M,Nordgren TM,Pellecchia M. (2020) Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease., 63 (21): [PMID:33107733 ] [10.1021/acs.jmedchem.0c01285 ]